1 / 31

Local Anesthetics LA

Local Anesthetics LA. LA: Reversibly block impulse conduction along nerve axons & other excitable membrane that utilize Na + channels for Action Potential generation. Uses : block pain sensation ( nociception ) from specific area of ! body.

faunus
Download Presentation

Local Anesthetics LA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Local Anesthetics LA

  2. LA: Reversibly block impulse conduction along nerve axons & other excitable membrane that utilize Na+ channels for Action Potential generation. • Uses: block pain sensation (nociception) from specific area of ! body. • Cocaine was ! 1st LA isolated from Coca plant as an ophthalmic anesthetic; Its chronic use: psychological dependence (addiction).

  3. Followed by procaine & then Lidocaine (Lid) which is ! most widely used LA. What characteristics of LAs make them ideal agents for anesthesia? As ropivacaine 1- Rapid onset, 2- Long Duration of Action, 3- Reversible & selective blockade of sensory nerves without motor blockade, 4- Minimal local tissue irritation & no systemic toxicities.

  4. Chemistry of LA • Weak base & available as salts to increase solubility & stability. • Consist of lipophilic gp (aromatic ring): memb penetration ++ intermediate chain via an ester or amide to ionizable gp: for channel blockade .

  5. •Absorption esp systemic: depends on: 1- dosage, 2- site of inj, (VASCULARITY): IV > tracheal > intercostals > paracervical > epidural > brachial plexus > sciatic > SC 3- drug-tissue binding, 4- local bld flow, 5- use of Vasoconstrictors (epinephrine/ phenylephrine) & 6- ! physiochemical property of ! drug. Absorption in highly vascular area is > poor perfused tissue.

  6. Epinephrine/ VC: Slow ! removal & reduce systemic absorption of LA from inj site by decreasing bld flow & cause higher local tissue conc of ! drug & prolong conduction blockade. + reduce CNS & systemic tox. Used with short/ intermediate duration of action: (procaine, Lid & mepivacaine). VCs are < effective in prolonging anesthetic action of more lipid-soluble, long-acting drugs (bupivacaine & ropivacaine) which are highly tissue-bound.

  7. Distribution ! Amide LAs are widely distributed after IV bolus inj. Initial rapid phase into highly perfused organs, then a slower phase to moderately perfused organs.

  8. Metabolism & Excretion • Acidification of urine: ionization & excretion of LA • Ester-type hydrolyzed rapidly in ! bld (by pseudo-choline-sterase) to inactive metabolite; short plasma t1/2 (< 1 min). • ! amide linkage is hydrolyzed by liver cyto P450 with diff rate (prilocaine (fastest) > Lid > mepivacaine > ropivacaine > bupivacaine (slowest). • All converted to water-soluble metabolites & excreted in urine.

  9. Toxicity from amide-type LA occur in hepatic D. Ex: elimination t1/2 of Lid from 1.6 hr in normal pat to > 6 hr in liver disease pat. • amide LA also affected by enz inhibitors. • Reduced hepatic bld flow: decrease their elimination.

  10. MOA • Block ! Initiation & propagation of AP by preventing voltage-gated Na+ channels. • Activity is PH-dependent, increased at alkaline PH. Its penetration to Na+ chs is very poor at acid PH. Inflamed tissues (acidic): resis to LA. • Elevated extracellular Ca2+ antagonizes ! action of LA by Ca2+ w increase! surface potential on ! membrane.

  11. Structure- Activity Characteristics of LA: • Smaller & more lipophilic LA: ! Faster rate of interaction with Na+ chs. • Potency is +vely correlated with lipid solubility. Lid, procaine, & mepivacaine are > water-soluble than tetracaine, bupivacaine, & ropivacaine that are more potent & have longer DOA. • Long acting (bupivacaine ) also bind more extensively to plasma proteins & can be displaced by other drugs.

  12. Other actions on nerves: 1- Loss of sensation from site of painful stimuli 2- Motor paralysis during surgery Disadvantages • In Spinal anesthesia, motor paralysis: impair respiratory activity & AN blockade: hypotension & urinary retention (catheterization).

  13. 1- Effect on fiber diameter: LA block conduction in small-diameter nerve fibers > readily than in large fibers. • Pain sensation is blocked > readily than other sensory modalities. • Motor axons (large diameter), are relatively resistance. • LAs block conduction in ! following order: small myelinated (nociceptive impulses), non- myelinated (C-fibers), large myelinated axons.

  14. 2- Effect on firing frequency • Blockade by LA is > at higher frequencies of depolarization. • Sensory (esp pain) fibers have High firing rate & long AP duration. while Motor fibers fire at a slower rate & have shorter AP duration.

  15. Properties of LAs

  16. Classification: Six Placement Sites • Surface/topical anesthesia • Local infiltration • Peripheral nerve block • Bier block (IV regional anesthesia) • Epidural anesthesia • Spinal anesthesia (subarachnoid)

  17. Epidural Spinal

  18. Clinical pharm Effective analgesia in specific regions of ! body. Route of administration: 1- Topical/ surface application (nasal mucosa, wound margins) 2-Inj in ! vicinity of peripheral nerve endings (infiltration) & major nerve trunks (blocks) 3- Inj into ! epidural or subarachnoid spaces surrounding ! spinal cord. 4- IV regional anesthesia (Bier block) for surgery < 60 min in limbs.

  19. Local Infiltration: Extravascular placement of ! LA in ! region to be anesthetized • Peripheral Nerve Block: LA inj into tissues around individual nerves or nerve plexuses (e.g. brachial plexus).

  20. DOA • Short: proc- & chloropro- caine • Intermediate: Lid, mepiva- & prilo- caine • Long-acting: tetra-, bupiva-, & ropiva- caine. • DOA can be prolonged by increasing ! Dose/ adding VC agent.

  21. To increase onset of LA: + Na-bicarbonate to LA sol. • Repeated inj of LA: tachyphylaxis (extracellular acidosis) • Pregnancy increase LA tox. • Topical LA: eye, ENT & for cosmetic surgery. Properties: 1- rapid penetration across ! skin/ mucosa & 2- low tendency to diffuse away from ! site of application. • Cocaine bec of excellent penetration & local VC used for (ENT) procedures. Has irritating effect so NOT used in ophthalmic procedure. • Other topical: Lid + VC, tetracaine, pramoxine, dibucaine, benzocaine, & dyclonine.

  22. OTHER USES: • LAs have membrane-stabilizing effects; Both IV Lid & po (mexiletine, tocainide) used to Tr pat with neuropathic pain syndrome: (uncontrolled, rapid, sensory fiber firing). • Systemic LA: as adjuncts to TCA (amitriptyline) & anticonvulsant (carbamazepine) combination. • Systemic toxicity: CNS & CV system.

  23. Toxicity A- CNS: 1- All LAs at low conc: sleepiness, light headiness, visual & auditory disturbances & restlessness. Early symp: tongue numbness + metallic taste. Rare, but High plasma conc.: nystagmus & muscular twitching, then tonic-clonic convulsions. Followed by generalized CNS depression (apnea).

  24. Convulsions: excessive LA level in ! bld. If large dose of LA is required: Rx pre-medication with BDZs prophylaxis. 2- For cocaine: widely abuse drug, severe CV toxicity; HTN, arrhythmia, & myocardial Failure. B- Neurotox: direct neuronal tox. With excessive high conc. Chloroprocaine & Lid are > neurotoxic than others in spinal anes.,: transient irritation (neuropathic symptoms).

  25. C- CVS: direct effect on ! hrt & smooth muscle & indirect effect on ! ANS. • Depress strength of cardiac contraction, ECG changes & cause arteriolar dilatation;; hypotension. • Cocaine blocks Norepinephrine uptake: VC & HTN + cardiac arrhythmia & ischemia. • Bupivacaine is > cardiotoxic than other long-acting LA. • Ropivaciane: CV & CNS tox, but < than Bupivacaine.

  26. D- Hematologic effects: Large dose of prilocaine: accumulation of Oxidizing Agent (o- toluidine) that convert Hg to metHg.;; cyanosis & chocolate-colored. Not recommended in infants. (Benzocaine can also cause metHg). Rx: IV methylene blue/ ascorbic acid. E- Allergic rxs: (Not e amides) Ester-type LAs are metabolized to P-ABA derivatives; allergic rxs.

More Related